Diltiazem Recruiting Phase 2 Trials for Flu caused by Influenza Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03212716Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.